TABLE 2.
BPND of 18F-SynVesT-2 Under Baseline and Blocking Conditions, and TRV of BPND
| Region | BP ND | Test–retest | ||
|---|---|---|---|---|
| Baseline (n = 9 subjects, 14 scans) | Blocking (n = 5) | TRV (n = 5) | aTRV (n = 5) | |
| Amygdala | 2.59 ± 0.31 | 0.43 ± 0.08 | 0.26% ± 9.90% | 7.38% ± 5.09% |
| Caudate nucleus | 2.03 ± 0.41 | 0.25 ± 0.1 | −2.73% ± 14.87% | 13.34% ± 5.12% |
| Cerebellum | 2.03 ± 0.18 | 0.25 ± 0.04 | −2.62% ± 10.93% | 9.77% ± 4.93% |
| Frontal lobe | 2.59 ± 0.34 | 0.4 ± 0.06 | −0.71% ± 11.78% | 9.96% ± 5.29% |
| Hippocampus | 1.76 ± 0.21 | 0.26 ± 0.07 | 3.08% ± 15.18% | 12.40% ± 5.09% |
| Occipital lobe | 2.72 ± 0.36 | 0.46 ± 0.09 | 0.74% ± 13.34% | 10.42% ± 5.27% |
| Parietal lobe | 2.69 ± 0.37 | 0.42 ± 0.09 | −0.33% ± 15.38% | 13.12% ± 6.88% |
| Putamen | 3.06 ± 0.29 | 0.58 ± 0.1 | −1.28% ± 10.59% | 9.36% ± 4.17% |
| Temporal lobe | 2.97 ± 0.37 | 0.51 ± 0.1 | 0.46% ± 12.72% | 10.69% ± 5.44% |
| Thalamus | 1.97 ± 0.24 | 0.33 ± 0.07 | −0.47% ± 17.23% | 14.15% ± 8.50% |
Data are mean ± SD.